Analysts Anticipate Molecular Templates, Inc. (NASDAQ:MTEM) Will Announce Quarterly Sales of $21.95 Million

Wall Street analysts expect Molecular Templates, Inc. (NASDAQ:MTEM – Get Rating) to post $21.95 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Molecular Templates’ earnings, with the lowest sales estimate coming in at $5.00 million and the highest estimate coming in at $37.50 million. Molecular Templates […]

Related Keywords

,Northern Trust Corp ,Zacks Investment Research ,Asset Management Americas Inc ,Molecular Templates Company Profile Get Rating ,Barclays ,Molecular Templates Inc ,Nasdaq ,Wall Street ,Molecular Templates ,Get Rating ,Molecular Template ,Investment Research ,Management Americas ,Sigma Investments ,Trust Corp ,Two Sigma Advisers ,Sigma Advisers ,Templates Company Profile ,Nasdaq Mtem ,Temtem ,Medical ,88580720 ,Ratings ,Consensus ,